Display options
Share it on

Nutr Diet Suppl. 2015;7:77-85. doi: 10.2147/NDS.S88888. Epub 2015 Oct 20.

Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats.

Nutrition and dietary supplements

Portia S Allen, Andrew W Brown, Michelle M Bohan Brown, Walter H Hsu, Donald C Beitz

Affiliations

  1. Department of Animal Science, Iowa State University, Ames, Iowa, United States of America.
  2. Nutrition Obesity Research Center and Office of Energetics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  3. Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa, United States of America.
  4. Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.

PMID: 26752960 PMCID: PMC4706234 DOI: 10.2147/NDS.S88888

Abstract

BACKGROUND: As prescriptions for off-label pharmaceutical use and autonomous administration of over-the-counter nutraceuticals become mainstream, thorough assessments of these compounds are warranted.

OBJECTIVE: To determine the effects of gemfibrozil, rosiglitazone, metformin, taurine, and vitamin E on body composition, hepatic lipids, and metabolic hormone and blood metabolite concentrations in a healthy, outbred rat cohort.

METHODS: Male Sprague Dawley rats were fed a purified 10 kcal% from fat diet for 56 days and assigned to diet alone (control) or diet plus oral administration of gemfibrozil (34 mg/kg), metformin (500 mg/kg), rosiglitazone (3 mg/kg), taurine (520 mg/kg), or vitamin E (200 mg/kg).

RESULTS: Rosiglitazone administration resulted in a 56% increase in carcass adiposity, cautioning potential prescriptive off-label use. Taurine supplementation had no adverse effects on evaluated parameters. A modest but significant increase in liver triacylglycerol content was observed with vitamin E supplementation compared with control (Δ 17.2 g triacylglycerol/100 g liver lipid).

CONCLUSIONS: The evaluated pharmaceuticals had effects in a healthy population similar to the reported effects in their target population and the nutraceuticals had minimal effects on the measured physiological parameters.

Keywords: animal model; gemfibrozil; metformin; thiazolidinedione

References

  1. J Biol Chem. 1988 Feb 25;263(6):2998-3004 - PubMed
  2. J Am Coll Cardiol. 2013 Aug 20;62(8):697-703 - PubMed
  3. Nat Rev Endocrinol. 2014 Mar;10(3):143-56 - PubMed
  4. J Nutr. 2011 Feb;141(2):261-6 - PubMed
  5. J Am Assoc Lab Anim Sci. 2010 May;49(3):316-22 - PubMed
  6. J Am Pharm Assoc Am Pharm Assoc. 1951 Mar;40(3):151-3 - PubMed
  7. Experientia. 1986 Apr 15;42(4):407-8 - PubMed
  8. Pharmacol Rep. 2005 Jul-Aug;57(4):498-503 - PubMed
  9. Circulation. 1998 Nov 10;98(19):2088-93 - PubMed
  10. Mayo Clin Proc. 2010 Nov;85(11):1033-41 - PubMed
  11. Free Radic Biol Med. 2007 Nov 15;43(10):1388-93 - PubMed
  12. Clin Endocrinol (Oxf). 2013 Aug;79(2):204-10 - PubMed
  13. Metabolism. 2010 Jan;59(1):46-53 - PubMed
  14. Adv Ther. 2009 Oct;26(10):893-907 - PubMed
  15. Br J Nutr. 1983 Sep;50(2):409-16 - PubMed
  16. Physiol Rev. 1992 Jan;72(1):101-63 - PubMed
  17. J Am Assoc Lab Anim Sci. 2006 Jan;45(1):98-105 - PubMed
  18. Clin Biochem. 1993 Feb;26(1):39-42 - PubMed
  19. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  20. J Biol Chem. 2012 Dec 28;287(53):44121-9 - PubMed
  21. J Nutr. 1977 Aug;107(8):1418-26 - PubMed
  22. J Agric Food Chem. 2003 Apr 9;51(8):2105-10 - PubMed
  23. Atherosclerosis. 1996 Nov 15;127(1):91-101 - PubMed
  24. Nutr J. 2003 Oct 07;2:9 - PubMed
  25. Arch Intern Med. 2006 May 8;166(9):1021-6 - PubMed
  26. Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E251-7 - PubMed
  27. Clin Chim Acta. 1993 Sep 30;218(2):223-8 - PubMed
  28. In Vivo. 2004 Jan-Feb;18(1):49-53 - PubMed
  29. Regul Toxicol Pharmacol. 2008 Apr;50(3):376-99 - PubMed
  30. Acta Biochim Pol. 2010;57(3):321-6 - PubMed

Publication Types

Grant support